{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:32:19Z","timestamp":1791844339007,"version":"4.3.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010463","name":"Institut Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010463","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["100326\/Z\/12\/Z"],"award-info":[{"award-number":["100326\/Z\/12\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["EQU202103012774"],"award-info":[{"award-number":["EQU202103012774"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006251","name":"Universit\u00e9 de Bordeaux","doi-asserted-by":"publisher","award":["17-1-AAE-11097"],"award-info":[{"award-number":["17-1-AAE-11097"]}],"id":[{"id":"10.13039\/501100006251","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006251","name":"Universit\u00e9 de Bordeaux","doi-asserted-by":"publisher","award":["17-1-FJC-11199"],"award-info":[{"award-number":["17-1-FJC-11199"]}],"id":[{"id":"10.13039\/501100006251","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006251","name":"Universit\u00e9 de Bordeaux","doi-asserted-by":"publisher","award":["20-2-AEQ-12822-2"],"award-info":[{"award-number":["20-2-AEQ-12822-2"]}],"id":[{"id":"10.13039\/501100006251","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006251","name":"Universit\u00e9 de Bordeaux","doi-asserted-by":"publisher","award":["22-2-AEQ-13411"],"award-info":[{"award-number":["22-2-AEQ-13411"]}],"id":[{"id":"10.13039\/501100006251","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006251","name":"Universit\u00e9 de Bordeaux","doi-asserted-by":"publisher","award":["VIH2016126002"],"award-info":[{"award-number":["VIH2016126002"]}],"id":[{"id":"10.13039\/501100006251","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ebiom.2023.104557","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T12:18:46Z","timestamp":1681301926000},"page":"104557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Primary role of type I interferons for the induction of functionally optimal antigen-specific CD8+ T cells in HIV infection"],"prefix":"10.1016","volume":"91","author":[{"given":"Mariela P.","family":"Cabral-Piccin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Papagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7124-1707","authenticated-orcid":false,"given":"Xavier","family":"Lahaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0119-8306","authenticated-orcid":false,"given":"Federico","family":"Perdomo-Celis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stevenn","family":"Volant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoghann","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Monceaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"Llewellyn-Lacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Fromentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9747-5018","authenticated-orcid":false,"given":"Nicolas","family":"Chomont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Manel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asier","family":"Saez-Cirion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Appay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2023.104557_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.192.1.63","article-title":"HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function","volume":"192","author":"Appay","year":"2000","journal-title":"J\u00a0Exp Med"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104557_bib2","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1084\/jem.192.12.1819","article-title":"Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children","volume":"192","author":"Goulder","year":"2000","journal-title":"J\u00a0Exp Med"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104557_bib3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.f.1774","article-title":"CD8+ T cell efficacy in vaccination and disease","volume":"14","author":"Appay","year":"2008","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104557_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-020-0274-9","article-title":"CD8+ T cells in HIV control, cure and prevention","volume":"20","author":"Collins","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104557_bib5","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104557_bib6","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20070784","article-title":"Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover","volume":"204","author":"Almeida","year":"2007","journal-title":"J\u00a0Exp Med"},{"issue":"14","key":"10.1016\/j.ebiom.2023.104557_bib7","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1182\/blood-2010-12-322727","article-title":"Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression","volume":"117","author":"Hersperger","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104557_bib8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.immuni.2008.10.010","article-title":"Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control","volume":"29","author":"Migueles","year":"2008","journal-title":"Immunity"},{"issue":"16","key":"10.1016\/j.ebiom.2023.104557_bib9","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1073\/pnas.0611244104","article-title":"HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex\u00a0vivo and peculiar cytotoxic T lymphocyte activation phenotype","volume":"104","author":"Saez-Cirion","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104557_bib10","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.4049\/jimmunol.172.10.6407","article-title":"The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration","volume":"172","author":"Betts","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"25","key":"10.1016\/j.ebiom.2023.104557_bib11","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1182\/blood-2009-02-206557","article-title":"Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity","volume":"113","author":"Almeida","year":"2009","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.ebiom.2023.104557_bib12","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1182\/blood-2012-04-422550","article-title":"Profound metabolic, functional, and cytolytic differences characterize HIV-specific CD8 T cells in primary and chronic HIV infection","volume":"120","author":"Trautmann","year":"2012","journal-title":"Blood"},{"issue":"377","key":"10.1016\/j.ebiom.2023.104557_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1809","article-title":"Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection","volume":"9","author":"Takata","year":"2017","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104557_bib14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.immuni.2012.09.005","article-title":"HIV and HLA class I: an evolving relationship","volume":"37","author":"Goulder","year":"2012","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104557_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm0496-405","article-title":"Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection","volume":"2","author":"Kaslow","year":"1996","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104557_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000791","article-title":"Common genetic variation and the control of HIV-1 in humans","volume":"5","author":"Fellay","year":"2009","journal-title":"PLoS Genet"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104557_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/rmv.1739","article-title":"Comparing HIV-1 and HIV-2 infection: lessons for viral immunopathogenesis","volume":"23","author":"Nyamweya","year":"2013","journal-title":"Rev Med Virol"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104557_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00042560-199712150-00003","article-title":"Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection","volume":"16","author":"Jaffar","year":"1997","journal-title":"J\u00a0Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104557_bib19","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1016\/S2352-3018(18)30254-6","article-title":"Long-term follow-up of HIV-2-related AIDS and mortality in Guinea-Bissau: a prospective open cohort study","volume":"6","author":"Esbjornsson","year":"2019","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ebiom.2023.104557_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1742-4690-7-46","article-title":"Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village","volume":"7","author":"van der Loeff","year":"2010","journal-title":"Retrovirology"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104557_bib21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/QAD.0b013e328344892e","article-title":"Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort","volume":"25","author":"Thiebaut","year":"2011","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104557_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12981-019-0239-x","article-title":"HIV-2 as a model to identify a functional HIV cure","volume":"16","author":"Esbjornsson","year":"2019","journal-title":"AIDS Res Ther"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104557_bib23","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/eji.200940295","article-title":"Highly avid, oligoclonal, early-differentiated antigen-specific CD8+ T cells in chronic HIV-2 infection","volume":"40","author":"Leligdowicz","year":"2010","journal-title":"Eur J Immunol"},{"issue":"21","key":"10.1016\/j.ebiom.2023.104557_bib24","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1182\/blood-2012-12-472787","article-title":"Correlates of T-cell-mediated viral control and phenotype of CD8+ T cells in HIV-2, a naturally contained human retroviral infection","volume":"121","author":"de Silva","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104557_bib25","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.4049\/jimmunol.1600693","article-title":"Preservation of lymphopoietic potential and virus suppressive capacity by CD8+ T cells in HIV-2-infected controllers","volume":"197","author":"Angin","year":"2016","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104557_bib26","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2013.11.002","article-title":"The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells","volume":"39","author":"Lahaye","year":"2013","journal-title":"Immunity"},{"issue":"7703","key":"10.1016\/j.ebiom.2023.104557_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41586-018-0050-1","article-title":"SAMHD1 acts at stalled replication forks to prevent interferon induction","volume":"557","author":"Coquel","year":"2018","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.ebiom.2023.104557_bib28","doi-asserted-by":"crossref","first-page":"E3798","DOI":"10.1073\/pnas.1801213115","article-title":"SAMHD1 suppresses innate immune responses to viral infections and inflammatory stimuli by inhibiting the NF-\u03baB and interferon pathways","volume":"115","author":"Chen","year":"2018","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104557_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-020-0198-7","article-title":"The interactions between cGAS-STING pathway and pathogens","volume":"5","author":"Cheng","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104557_bib30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cell.2018.08.062","article-title":"NONO detects the nuclear HIV capsid to promote cGAS-mediated innate immune activation","volume":"175","author":"Lahaye","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104557_bib31","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/s41564-022-01247-0","article-title":"Evasion of cGAS and TRIM5 defines pandemic HIV","volume":"7","author":"Zuliani-Alvarez","year":"2022","journal-title":"Nat Microbiol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104557_bib32","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1128\/JVI.01937-07","article-title":"Genetic recombination between human immunodeficiency virus type 1 (HIV-1) and HIV-2, two distinct human lentiviruses","volume":"82","author":"Motomura","year":"2008","journal-title":"J\u00a0Virol"},{"issue":"13","key":"10.1016\/j.ebiom.2023.104557_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aai8071","article-title":"Constitutive resistance to viral infection in human CD141+ dendritic cells","volume":"2","author":"Silvin","year":"2017","journal-title":"Sci Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104557_bib34","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1084\/jem.20130566","article-title":"CD36-specific antibodies block release of HIV-1 from infected primary macrophages and its transmission to T cells","volume":"210","author":"Berre","year":"2013","journal-title":"J\u00a0Exp Med"},{"issue":"7312","key":"10.1016\/j.ebiom.2023.104557_bib35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature09337","article-title":"A\u00a0cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells","volume":"467","author":"Manel","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2023.104557_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.07916","article-title":"Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients","volume":"4","author":"Alanio","year":"2015","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104557_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/acel.12384","article-title":"Reduced naive CD8+ T-cell priming efficacy in elderly adults","volume":"15","author":"Briceno","year":"2016","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104557_bib38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4049\/jimmunol.1501140","article-title":"Priming of qualitatively superior human effector CD8+ T cells using TLR8 ligand combined with FLT3 ligand","volume":"196","author":"Lissina","year":"2016","journal-title":"J\u00a0Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104557_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125107","article-title":"The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells","volume":"4","author":"Gutjahr","year":"2019","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104557_bib40","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.4049\/jimmunol.1602131","article-title":"Cutting edge: a dual TLR2 and TLR7 ligand induces highly potent humoral and cell-mediated immune responses","volume":"198","author":"Gutjahr","year":"2017","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104557_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67704-0","article-title":"The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8+ T-cell responses in\u00a0vitro","volume":"10","author":"Papagno","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2023.104557_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102922","article-title":"New chimeric TLR7\/NOD2 agonist is a potent adjuvant to induce mucosal immune responses","volume":"58","author":"Gutjahr","year":"2020","journal-title":"eBioMedicine"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104557_bib43","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.20051357","article-title":"Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses","volume":"202","author":"Price","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104557_bib44","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s42255-019-0081-4","article-title":"Metabolic plasticity of HIV-specific CD8+ T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection","volume":"1","author":"Angin","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.ebiom.2023.104557_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1034\/j.1600-065X.2002.18808.x","article-title":"Antigenicity and immunogenicity of Melan-A\/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma","volume":"188","author":"Romero","year":"2002","journal-title":"Immunol Rev"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104557_bib46","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.190.5.705","article-title":"High frequencies of naive Melan-A\/MART-1-specific CD8+ T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals","volume":"190","author":"Pittet","year":"1999","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ebiom.2023.104557_bib47","first-page":"7","article-title":"Functional analysis of HLA-A\u22170201\/Melan-A peptide multimer+ CD8+ T cells isolated from an HLA-A\u22170201- donor: exploring tumor antigen allorestricted recognition","volume":"2","author":"Dutoit","year":"2002","journal-title":"Cancer Immun"},{"issue":"25","key":"10.1016\/j.ebiom.2023.104557_bib48","doi-asserted-by":"crossref","first-page":"13812","DOI":"10.1073\/pnas.240469997","article-title":"Higher macrophage inflammatory protein (MIP)-1\u03b1 and MIP-1\u03b2 levels from CD8+ T cells are associated with asymptomatic HIV-1 infection","volume":"97","author":"Cocchi","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104557_bib49","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.celrep.2015.09.069","article-title":"A\u00a0critical role of IL-21-induced BATF in sustaining CD8-T-cell-mediated chronic viral control","volume":"13","author":"Xin","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2023.104557_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ebiom.2019.03.078","article-title":"Priming of HIV-1-specific CD8+ T cells with strong functional properties from naive T cells","volume":"42","author":"Kuse","year":"2019","journal-title":"eBioMedicine"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104557_bib51","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.4049\/jimmunol.1201150","article-title":"Cutting edge: generation of memory precursors and functional memory CD8+ T cells depends on T cell factor-1 and lymphoid enhancer-binding factor-1","volume":"189","author":"Zhou","year":"2012","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104557_bib52","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.immuni.2013.07.013","article-title":"The transcription factor Foxo 1 controls central-memory CD8+ T cell responses to infection","volume":"39","author":"Kim","year":"2013","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104557_bib53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/jb\/mvs149","article-title":"BAG6\/BAT3: emerging roles in quality control for nascent polypeptides","volume":"153","author":"Kawahara","year":"2013","journal-title":"J\u00a0Biochem"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104557_bib54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11904-014-0244-6","article-title":"Type I interferon: understanding its role in HIV pathogenesis and therapy","volume":"12","author":"Bosinger","year":"2015","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104557_bib55","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1182\/blood-2010-06-288035","article-title":"HIV disease progression correlates with the generation of dysfunctional naive CD8low T cells","volume":"117","author":"Favre","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104557_bib56","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood.V98.10.3016","article-title":"Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection","volume":"98","author":"Pacanowski","year":"2001","journal-title":"Blood"},{"issue":"5178","key":"10.1016\/j.ebiom.2023.104557_bib57","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1126\/science.7915856","article-title":"Reduced rate of disease development after HIV-2 infection as compared to HIV-1","volume":"265","author":"Marlink","year":"1994","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104557_bib58","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.4049\/jimmunol.176.11.6973","article-title":"Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection","volume":"176","author":"Duvall","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104557_bib59","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/eji.200737768","article-title":"Polyfunctional T cell responses are a hallmark of HIV-2 infection","volume":"38","author":"Duvall","year":"2008","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104557_bib60","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/mi.2017.44","article-title":"HIV-2 infection is associated with preserved GALT homeostasis and epithelial integrity despite ongoing mucosal viral replication","volume":"11","author":"Fernandes","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104557_bib61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.imlet.2014.10.028","article-title":"How does the humoral response to HIV-2 infection differ from HIV-1 and can this explain the distinct natural history of infection with these two human retroviruses?","volume":"163","author":"Makvandi-Nejad","year":"2015","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104557_bib62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4049\/jimmunol.171.1.307","article-title":"Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection","volume":"171","author":"Lopes","year":"2003","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104557_bib63","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2023.104557_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.606456","article-title":"Type I interferon (IFN)-regulated activation of canonical and non-canonical signaling pathways","volume":"11","author":"Mazewski","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2023.104557_bib65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cytogfr.2018.03.004","article-title":"Interferon-associated therapies toward HIV control: the back and forth","volume":"40","author":"Noel","year":"2018","journal-title":"Cytokine Growth Factor Rev"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104557_bib66","first-page":"3544","article-title":"Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response","volume":"119","author":"Jacquelin","year":"2009","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104557_bib67","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11904-019-00444-7","article-title":"Pathogenic role of type I interferons in HIV-induced immune impairments in humanized mice","volume":"16","author":"Su","year":"2019","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"17","key":"10.1016\/j.ebiom.2023.104557_bib68","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1128\/JVI.00457-11","article-title":"Type I interferon contributes to CD4+ T cell depletion induced by infection with HIV-1 in the human thymus","volume":"85","author":"Sivaraman","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ebiom.2023.104557_bib69","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-immunol-051116-052155","article-title":"Immune responses to retroviruses","volume":"36","author":"Saez-Cirion","year":"2018","journal-title":"Annu Rev Immunol"},{"issue":"24","key":"10.1016\/j.ebiom.2023.104557_bib70","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1128\/JVI.02360-14","article-title":"Type I interferon signaling enhances CD8+ T cell effector function and differentiation during murine gammaherpesvirus 68 infection","volume":"88","author":"Jennings","year":"2014","journal-title":"J\u00a0Virol"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104557_bib71","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00002030-200308150-00002","article-title":"Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-\u03b1 are potent inducers of HIV-specific CD8 T cells","volume":"17","author":"Carbonneil","year":"2003","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104557_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004930","article-title":"Potent cell-intrinsic immune responses in dendritic cells facilitate HIV-1-specific T cell immunity in HIV-1 elite controllers","volume":"11","author":"Martin-Gayo","year":"2015","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104557_bib73","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.celrep.2016.07.002","article-title":"Restriction by SAMHD1 limits cGAS\/STING-dependent innate and adaptive immune responses to HIV-1","volume":"16","author":"Maelfait","year":"2016","journal-title":"Cell Rep"},{"issue":"7887","key":"10.1016\/j.ebiom.2023.104557_bib74","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41586-021-04054-5","article-title":"Self-guarding of MORC3 enables virulence factor-triggered immunity","volume":"600","author":"Gaidt","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104557_bib75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41591-020-01145-0","article-title":"Modeling human adaptive immune responses with tonsil organoids","volume":"27","author":"Wagar","year":"2021","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104557_bib76","doi-asserted-by":"crossref","first-page":"e01541","DOI":"10.1128\/JVI.01541-18","article-title":"Interferon alpha enhances NK cell function and the suppressive capacity of HIV-specific CD8+ T cells","volume":"93","author":"Kwaa","year":"2019","journal-title":"J\u00a0Virol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104557_bib77","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4049\/jimmunol.1900811","article-title":"CTL clonotypes with higher TCR affinity have better ability to reduce the HIV latent reservoir","volume":"205","author":"Lima","year":"2020","journal-title":"J\u00a0Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104557_bib78","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202152447","article-title":"Inclusion of cGAMP within virus-like particle vaccines enhances their immunogenicity","volume":"22","author":"Chauveau","year":"2021","journal-title":"EMBO Rep"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104557_bib79","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/14760584.2019.1675518","article-title":"Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials","volume":"18","author":"Hanke","year":"2019","journal-title":"Expert Rev Vaccines"},{"issue":"6253","key":"10.1016\/j.ebiom.2023.104557_bib80","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1126\/science.aab3628","article-title":"Transmission of innate immune signaling by packaging of cGAMP in viral particles","volume":"349","author":"Gentili","year":"2015","journal-title":"Science"},{"issue":"6253","key":"10.1016\/j.ebiom.2023.104557_bib81","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.aab3632","article-title":"Viruses transfer the antiviral second messenger cGAMP between cells","volume":"349","author":"Bridgeman","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104557_bib82","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.1038\/s41598-019-42253-3","article-title":"STING agonists activate latently infected cells and enhance SIV-specific responses ex\u00a0vivo in naturally SIV controlled cynomolgus macaques","volume":"9","author":"Yamamoto","year":"2019","journal-title":"Sci Rep"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423001226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423001226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:23:34Z","timestamp":1762457014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423001226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":82,"alternative-id":["S2352396423001226"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104557","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary role of type I interferons for the induction of functionally optimal antigen-specific CD8+ T cells in HIV infection","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104557"}}